Condensed Consolidated Financial Statement Details - Narrative (Details) $ in Thousands			3 Months Ended			9 Months Ended
	Mar. 04, 2024 USD ($)	Dec. 16, 2020 USD ($)	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Goodwill [Line Items]
Impairment of other property, plant and equipment			$ 0		$ 10,173	$ 8,329	$ 36,628
2012 Purchase and Sale Agreement
Goodwill [Line Items]
Royalties liability discount rate			0.43			0.43
2020 Purchase and Sale Agreement
Goodwill [Line Items]
Royalties liability discount rate			0.24			0.24
Payment of transaction related to purchase and sale agreement		$ 210,000
Payment of transaction related to purchase and sale agreement if threshold is not achieved		$ 240,000
Amount exchanged to remove cap on royalties	$ 15,000
Proceeds from sale of royalty rights						$ 15,000
UCB Pharma Manufacturing Agreement
Goodwill [Line Items]
Net realizable value of assets			$ 0			$ 0		$ 2,000
Provision for inventory			$ 0
Sublease of Laboratory and Office Space
Goodwill [Line Items]
Impairment of other property, plant and equipment				$ 1,000